Management and potentialities of primary cancer cultures in preclinical and translational studies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Management and potentialities of primary cancer cultures in preclinical and translational studies ; volume:15 ; number:1 ; day:7 ; month:11 ; year:2017 ; pages:1-16 ; date:12.2017
Journal of translational medicine ; 15, Heft 1 (7.11.2017), 1-16, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Miserocchi, Giacomo
- Beteiligte Personen und Organisationen
-
Mercatali, Laura
Liverani, Chiara
De Vita, Alessandro
Spadazzi, Chiara
Pieri, Federica
Bongiovanni, Alberto
Recine, Federica
Amadori, Dino
Ibrahim, Toni
SpringerLink (Online service)
- DOI
-
10.1186/s12967-017-1328-z
- URN
-
urn:nbn:de:1111-201801059017
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Miserocchi, Giacomo
- Mercatali, Laura
- Liverani, Chiara
- De Vita, Alessandro
- Spadazzi, Chiara
- Pieri, Federica
- Bongiovanni, Alberto
- Recine, Federica
- Amadori, Dino
- Ibrahim, Toni
- SpringerLink (Online service)
Ähnliche Objekte (12)
Nutraceuticals in Chronic Coronary Syndromes: Preclinical Data and Translational Experiences
Is translational research compatible with preclinical publication strategies?
Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development
Cancer interception by interceptor molecules: mechanistic, preclinical and human translational studies with chlorophylls
Phase III Preclinical Trials in Translational Stroke Research: Community Response on Framework and Guidelines
Hyperexcitability and translational phenotypes in a preclinical mouse model of SYNGAP1-related intellectual disability
Preclinical progress and first translational research steps for a novel liposomal chemotherapy against adrenocortical carcinoma
Impaired learning, memory, and extinction in posttraumatic stress disorder: translational meta-analysis of clinical and preclinical studies
Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease
Preclinical Pharmacokinetics and Translational Pharmacokinetic/Pharmacodynamic Modeling of M8891, a Potent and Reversible Inhibitor of Methionine Aminopeptidase 2
Bridging the translational gap: adenosine as a modulator of neuropathic pain in preclinical models and humans
Advancing preclinical models of psychiatric disorders with human brain organoid cultures
Nutraceuticals in Chronic Coronary Syndromes: Preclinical Data and Translational Experiences
Is translational research compatible with preclinical publication strategies?
Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development
Cancer interception by interceptor molecules: mechanistic, preclinical and human translational studies with chlorophylls
Phase III Preclinical Trials in Translational Stroke Research: Community Response on Framework and Guidelines
Hyperexcitability and translational phenotypes in a preclinical mouse model of SYNGAP1-related intellectual disability
Preclinical progress and first translational research steps for a novel liposomal chemotherapy against adrenocortical carcinoma
Impaired learning, memory, and extinction in posttraumatic stress disorder: translational meta-analysis of clinical and preclinical studies
Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease
Preclinical Pharmacokinetics and Translational Pharmacokinetic/Pharmacodynamic Modeling of M8891, a Potent and Reversible Inhibitor of Methionine Aminopeptidase 2
Bridging the translational gap: adenosine as a modulator of neuropathic pain in preclinical models and humans
Advancing preclinical models of psychiatric disorders with human brain organoid cultures
Nutraceuticals in Chronic Coronary Syndromes: Preclinical Data and Translational Experiences
Is translational research compatible with preclinical publication strategies?
Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development
Cancer interception by interceptor molecules: mechanistic, preclinical and human translational studies with chlorophylls
Phase III Preclinical Trials in Translational Stroke Research: Community Response on Framework and Guidelines
Hyperexcitability and translational phenotypes in a preclinical mouse model of SYNGAP1-related intellectual disability
Preclinical progress and first translational research steps for a novel liposomal chemotherapy against adrenocortical carcinoma
Impaired learning, memory, and extinction in posttraumatic stress disorder: translational meta-analysis of clinical and preclinical studies
Preclinical translational platform of neuroinflammatory disease biology relevant to neurodegenerative disease
Preclinical Pharmacokinetics and Translational Pharmacokinetic/Pharmacodynamic Modeling of M8891, a Potent and Reversible Inhibitor of Methionine Aminopeptidase 2
Bridging the translational gap: adenosine as a modulator of neuropathic pain in preclinical models and humans